BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28767733)

  • 21. Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma.
    Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    J Cancer Res Clin Oncol; 1998; 124(3-4):215-9. PubMed ID: 9619749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of creatine kinase isozymes in sera and tissues of patients with various lung carcinomas.
    Usui A; Fujita K; Imaizumi M; Abe T; Inoue K; Matumoto S; Kato K
    Clin Chim Acta; 1987 Apr; 164(1):47-53. PubMed ID: 3034455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment serum LDH as additional staging parameter in small-cell lung carcinoma.
    Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    Neth J Med; 1998 Feb; 52(2):65-70. PubMed ID: 9557528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.
    Vlachostergios PJ; Oikonomou KG; Gibilaro E; Apergis G
    Cancer Biomark; 2015; 15(6):725-34. PubMed ID: 26406401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of telomerase in patients with non-small cell lung cancer: prediction of metastasis and prognostic significance.
    Aras G; Kanmaz D; Urer N; Purisa S; Kadakal F; Yentürk E; Tuncay E
    Anticancer Res; 2013 Jun; 33(6):2643-50. PubMed ID: 23749922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
    Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
    Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overall survival and prognostic factors in patients with spinal metastases from lung cancer treated with and without epidermal growth factor receptor tyrosine kinase inhibitors.
    Dohzono S; Sasaoka R; Takamatsu K; Nakamura H
    Int J Clin Oncol; 2017 Aug; 22(4):698-705. PubMed ID: 28361340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation Analysis of Serum LDH Concentration before and after Operation and Prognosis of Large Cell Neuroendocrine Lung Cancer Patients].
    Wang H; Shan D; Dong Y; Yang X; Yu Z
    Zhongguo Fei Ai Za Zhi; 2021 May; 24(5):351-356. PubMed ID: 34034459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of serum cardiac enzymes after intracoronary thrombolytic therapy. Creatine kinase, creatine kinase MB isozyme, lactate dehydrogenase, and serum glutamic-oxaloacetic transaminase.
    Wei JY; Markis JE; Malagold M; Grossman W
    Arch Intern Med; 1985 Sep; 145(9):1596-600. PubMed ID: 4026489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum creatine kinase and lactate dehydrogenase activities in patients with thyroid disorders.
    McGrowder DA; Fraser YP; Gordon L; Crawford TV; Rawlins JM
    Niger J Clin Pract; 2011; 14(4):454-9. PubMed ID: 22248949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
    Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
    J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK19 reverse transcriptase polymerase chain reaction and its clinical significance.
    Ge MJ; Wu QC; Wang M; Zhang YH; Li LB
    J Cancer Res Clin Oncol; 2005 Oct; 131(10):662-8. PubMed ID: 16047189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
    Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.
    Quintanal-Villalonga Á; Carranza-Carranza A; Meléndez R; Ferrer I; Molina-Pinelo S; Paz-Ares L
    Clin Lung Cancer; 2017 Nov; 18(6):667-674.e1. PubMed ID: 28583379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of morphologic findings for lung squamous cell carcinoma patients.
    Gürel D; Ulukuş Ç; Karaçam V; Ellidokuz H; Umay C; Öztop İ; Sarıoğlu S
    Pathol Res Pract; 2016 Jan; 212(1):1-9. PubMed ID: 26608418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactate dehydrogenase is a prognostic indicator for prostate cancer patients with bone metastasis.
    Naruse K; Yamada Y; Aoki S; Taki T; Nakamura K; Tobiume M; Zennami K; Katsuda R; Sai S; Nishio Y; Inoue Y; Noguchi H; Hondai N
    Hinyokika Kiyo; 2007 May; 53(5):287-92. PubMed ID: 17561711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
    Xu XY; Lin N; Li YM; Zhi C; Shen H
    Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer.
    Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Tamura T; Yatabe T; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Gastric Cancer; 2019 Jul; 22(4):684-691. PubMed ID: 30417313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy.
    Jin Y; Ye X; Shao L; Lin BC; He CX; Zhang BB; Zhang YP
    Eur J Cancer; 2013 May; 49(7):1619-26. PubMed ID: 23266049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
    Shimizu K; Maeda A; Yukawa T; Nojima Y; Saisho S; Okita R; Nakata M
    World J Surg Oncol; 2014 Nov; 12():343. PubMed ID: 25392182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.